New research published in the Lancet indicates that thousands
of lives could have been saved each year in the UK from heart attacks,
but substandard care for victims means that the UK is lagging behind
other countries in Europe.
The failure to administer rapid treatment and good quality aftercare
has resulted in the loss of at least 11,000 lives in the last seven
years, with death rates one third higher than other countries.
The study involved researchers from the
UK and Sweden looking at information regarding the care and outcomes of
120,000 heart attack patients across hospitals in Sweden and more than
390,000 in the UK between 2004 and 2010.
Sweden was picked for comparison because its health system is
comparable; universally available, receives it’s funding from tax, with
no cost at the point of use. Both also have national guidance
implemented for heart attack management, although the two countries
drastically differ in size with the population in excess of 63 million,
whereas Sweden only has a population of between nine and 10 million.
After just 30 days of the occurrence of a heart attack, death rates
were discovered to be over a third higher in the UK than Sweden – 10.5%
compared with 7.6%.
Over time, the difference in death rates between the two countries
decreased, but the UK always had higher mortality, but mortality was
always higher in the UK.
Even considering factors like age, sex, the severity of heart
attacks, smoking, blood pressure and diabetes, researchers still
estimated 11,263 deaths between 2004 and 2010 could have been “delayed
or prevented” if patients in the UK had received treatment in the same
standard as their Swedish counterparts.
It may also be a concern to learn that the study found patients in
Sweden were significantly more like to get quick treatment to help
unblock their arteries.
Only 22% of UK patients received balloon angioplasty or stent
placements, however a staggering 59% of heart attack patients in Sweden
received such treatments.
It gets worse; upon being discharged from hospital, 89% of the
Swedish patients were prescribed medications such as beta blockers, with
this figure being 11% higher than that in the UK.
Lead author Professor Harry Hemingway, from the National Institute
for Cardiovascular Outcomes Research at University College London, said:
“Our findings are a cause for concern. The uptake and use of new
technologies and effective treatments recommended in guidelines has been
far quicker in Sweden. This has contributed to large differences in the
management and outcomes of patients.”
NHS England claim that things are improving though, with National
Clinical Director for cardiac care, Professor Huon Gray, saying: “The
advanced treatment patients now receive in the UK means heart attack
death rates have fallen from one in four in the 1970s, to one in 20 now,
but we know more needs to be done and we are working hard to further
improve survival rates.”
No comments:
Post a Comment